Quantitative Magnetic Resonance Imaging of Pulmonary Hypertension
- 1 March 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Thoracic Imaging
- Vol. 29 (2) , 68-79
Abstract
Pulmonary hypertension is a condition of varied etiology, commonly associated with poor clinical outcome. Patients are categorized on the basis of pathophysiological, clinical, radiologic, and therapeutic similarities. Pulmonary arterial hypertension (PAH) is often diagnosed late in its disease course, with outcome dependent on etiology, disease severity, and response to treatment. Recent advances in quantitative magnetic resonance imaging (MRI) allow for better initial characterization and measurement of the morphologic and flow-related changes that accompany the response of the heart-lung axis to prolonged elevation of pulmonary arterial pressure and resistance and provide a reproducible, comprehensive, and noninvasive means of assessing the course of the disease and response to treatment. Typical features of PAH occur primarily as a result of increased pulmonary vascular resistance and the resultant increased right ventricular (RV) afterload. Several MRI-derived diagnostic markers have emerged, such as ventricular mass index, interventricular septal configuration, and average pulmonary artery velocity, with diagnostic accuracy similar to that of Doppler echocardiography. Furthermore, prognostic markers have been identified with independent predictive value for identification of treatment failure. Such markers include large RV end-diastolic volume index, low left ventricular end-diastolic volume index, low RV ejection fraction, and relative area change of the pulmonary trunk. MRI is ideally suited for longitudinal follow-up of patients with PAH because of its noninvasive nature and high reproducibility and is advantageous over other biomarkers in the study of PAH because of its sensitivity to change in morphologic, functional, and flow-related parameters. Further study on the role of MRI image based biomarkers in the clinical environment is warranted.Keywords
This publication has 126 references indexed in Scilit:
- New index alpha improves detection of pulmonary hypertension in comparison with other cardiac magnetic resonance indicesInternational Journal of Cardiology, 2012
- Cardiovascular magnetic resonance in pulmonary hypertensionJournal of Cardiovascular Magnetic Resonance, 2012
- Interleaved variable density sampling with a constrained parallel imaging reconstruction for dynamic contrast‐enhanced MR angiographyMagnetic Resonance in Medicine, 2011
- Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonanceJournal of Cardiovascular Magnetic Resonance, 2011
- Time‐resolved magnetic resonance angiography: Evaluation of intrapulmonary circulation parameters in pulmonary arterial hypertensionJournal of Magnetic Resonance Imaging, 2010
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- A meta-analysis of randomized controlled trials in pulmonary arterial hypertensionEuropean Heart Journal, 2008
- Reproducibility of MRI measurements of right ventricular size and function in patients with normal and dilated ventriclesJournal of Magnetic Resonance Imaging, 2008
- Valvular heart disease: what does cardiovascular MRI add?European Radiology, 2007
- Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004